Reduction of MCP-1 and MIF by a Polyphenol-rich extract in subjects with clustered cardiometabolic risk factors
暂无分享,去创建一个
P. Hugenholtz | W. Koenig | A. Stalmach | A. Crozier | H. Vink | B. Hutten | J. Kastelein | DF van Wijk
[1] P. Libby. Inflammation in Atherosclerosis , 2012, Arteriosclerosis, thrombosis, and vascular biology.
[2] M. Nieuwdorp,et al. Effect of sulodexide on endothelial glycocalyx and vascular permeability in patients with type 2 diabetes mellitus , 2010, Diabetologia.
[3] M. Weigand,et al. Sepsis-Induced Degradation of Endothelial Glycocalix , 2010, TheScientificWorldJournal.
[4] J. Kastelein,et al. Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis , 2007, Diabetologia.
[5] R. Heine,et al. Endothelial glycocalyx damage coincides with microalbuminuria in type 1 diabetes. , 2006, Diabetes.
[6] J. Kastelein,et al. Loss of endothelial glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and coagulation activation in vivo. , 2006, Diabetes.
[7] Hans Vink,et al. The Endothelial Glycocalyx Protects Against Myocardial Edema , 2003, Circulation research.
[8] J. Kastelein,et al. Tumor necrosis factor-alpha inhibition protects against endotoxin-induced endothelial glycocalyx perturbation. , 2009, Atherosclerosis.